Rhythm Control in AF: Have We Reached the Last Frontier?

European Cardiology
Gheorghe-Andrei Dan

Abstract

AF is a worldwide epidemic, affecting approximately 33 million people, and its rising prevalence is expected to account for increasing clinical and public health costs. AF is associated with an increased risk of MI, heart failure, stroke, dementia, chronic kidney disease and mortality. Preserving sinus rhythm is essential for a better outcome. However, because of the inherent limits of both pharmacological and interventional methods, rhythm strategy management is reserved for symptom and quality-of-life improvement. While 'classical' antiarrhythmic drug therapy remains the first-line therapy for rhythm control, its efficacy and safety are limited by empirical use, proarrhythmic risk and organ toxicity. Ablative techniques have had an impressive development, but AF ablation still failed to demonstrate a significant impact on hard endpoints. Understanding of the complex mechanisms of AF will help to develop new vulnerable targets to therapy. Promising molecules are under development, intended to fill the gap between the current pharmacological treatment aimed at maintaining sinus rhythm and the expectations from rhythm strategy.

References

Dec 19, 2007·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Francisco G CosioHarry Crijns
Feb 14, 2009·The New England Journal of Medicine·Stefan H HohnloserUNKNOWN ATHENA Investigators
Jun 6, 2009·Journal of Cardiovascular Electrophysiology·Nikolaos DagresChristopher Piorkowski
Nov 16, 2010·Circulation. Arrhythmia and Electrophysiology·Peter Leong-SitEdward P Gerstenfeld
Nov 16, 2011·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN PALLAS Investigators
Dec 25, 2012·Future Cardiology·Jordi HeijmanDobromir Dobrev
Apr 18, 2013·Nature Reviews. Cardiology·Dawood Darbar, Dan M Roden
Nov 2, 2013·American Heart Journal·Nancy M Allen LaPointeSana M Al-Khatib
Feb 11, 2014·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Jonathan S SteinbergSuneet Mittal
Dec 11, 2014·The American Journal of Cardiology·Nancy M Allen LaPointeSana M Al-Khatib
Mar 31, 2015·The Cochrane Database of Systematic Reviews·Carmelo Lafuente-LafuenteJoël Belmin
Aug 22, 2015·Journal of the American College of Cardiology·Mikhail S DzeshkaEduard Shantsila
Sep 30, 2015·European Heart Journal·Kazuaki KaitaniUNKNOWN EAST-AF Trial Investigators
Feb 4, 2016·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Cas TeunissenPeter Loh
Jul 13, 2016·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Andreas GoetteUNKNOWN Document Reviewers:
Nov 4, 2016·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Paulus KirchhofKatja Zeppenfeld
Jan 21, 2017·European Heart Journal·Elena ArbeloUNKNOWN on the behalf of the ESC-EHRA Atrial Fibrillation Ablation Long-term Registry Investigators
Apr 4, 2017·International Journal of Cardiology·A John Camm
Aug 5, 2017·Journal of the American College of Cardiology·Jean-Baptiste Guichard, Stanley Nattel
Sep 1, 2017·Journal of the American College of Cardiology·Sandeep PrabhuPeter M Kistler
Oct 11, 2017·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Hugh CalkinsTeiichi Yamane
Oct 19, 2017·European Heart Journal·John G F ClelandUNKNOWN Beta-blockers in Heart Failure Collaborative Group
Nov 9, 2017·JAMA Cardiology·Milton Packer
Dec 22, 2017·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Jock A ClarnettePrashanthan Sanders
Feb 1, 2018·The New England Journal of Medicine·Nassir F MarroucheUNKNOWN CASTLE-AF Investigators
Mar 15, 2018·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Hein HeidbuchelAlec Vahanian
Mar 30, 2018·European Heart Journal·Sean D Pokorney, James P Daubert
May 15, 2018·American Heart Journal·Douglas L PackerUNKNOWN CABANA Investigators
Jun 13, 2018·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Gheorghe-Andrei DanGregory Y H Lip
Sep 19, 2018·IJC Heart & Vasculature·Gheorghe-Andrei Dan, Dobromir Dobrev
Nov 9, 2018·Kardiologia polska·Gerhard HindricksNikolaos Dagres

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Related Papers

Journal of Atrial Fibrillation
Gulmira Kudaiberdieva, Bulent Gorenek
International Journal of Cardiology
Chern-En ChiangCharn Sriratanasathavorn
© 2021 Meta ULC. All rights reserved